Announcements

Toronto, September 16, 2018 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce the submission of it’s Analytical Testing license application in Health Canada’s new Cannabis Tracking and Licensing System (CTLS). “Health Canada informed us that due to our previously submitted Licensed Dealer (LD) application (#6-1114), Vivariant would be given early access to the CTLS to submit any new license applications under the forthcoming framework.” President Thomas Fraleigh said from the company’s site in Mississauga. “This allowed us to submit an early application for the new analytical testing license under the Cannabis Act before the rest…

Toronto, September 05, 2018 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce the appointment of Anand Thota to the role of Chief Microbiologist. Before joining Vivariant, Anand held the position of Senior Microbiologist at Eurofins Experchem performing a variety of microbiological testing techniques on Cannabis in a GMP/GLP environment. He has worked directly on site with several Cannabis industry clients monitoring environmental conditions for microbes in growing environments as well as water quality projects. “Anand has a significant amount of experience in microbiology testing of Cannabis,” President Thomas Fraleigh said. “In addition to his technical…

Toronto, May 29, 2018 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce the submission of an application for a Licensed Dealer (LD) Permit to Health Canada in order to conduct analytical testing activities with Cannabis from Licensed Producers (LPs) and Medical Patients under the MMPR/ACMPR. “We are excited to call ourselves an LD applicant and to have passed this milestone on our journey. We look forward to a thoughtful dialogue with Health Canada” President Thomas Fraleigh said. “I would like to thank our whole team for their diligent and attentive work putting the security proposal…